Please wait...
161
172
Offers Claimed: 169
Downloaded Today: 29
Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:
Note: This document contains side effect information about brimonidine topical. Some of the dosage forms listed on this page may not apply to the brand name Mirvaso.
In SummaryCommon side effects of Mirvaso include: flushing. Other side effects include: burning sensation of skin and erythema of skin. See below for a comprehensive list of adverse effects.
For the ConsumerApplies to brimonidine topical: topical application gel/jelly
Along with its needed effects, brimonidine topical (the active ingredient contained in Mirvaso) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking brimonidine topical:
More common
Less common
Some side effects of brimonidine topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
For Healthcare Professionals
Applies to brimonidine topical: topical gel
GeneralThe most commonly reported adverse reactions are headache, erythema, pruritus, flushing and skin burning sensation.
DermatologicCommon (1% to 10%): Acne, allergic contact dermatitis, contact dermatitis, dermatitis, erythema, pruritus, rosacea, skin burning sensation, skin irritation, skin pain, warm skin
Uncommon (0.1% to 1%): Dry skin, skin discomfort, papular rash
Postmarketing reports: Aggravated erythema, face swelling, pallor, urticaria
RespiratoryCommon (1% to 10%): Nasal congestion, nasopharyngitis, upper respiratory track infection
Postmarketing reports: Throat tightness
OcularCommon (1% to 10%): Blurred vision, increased intraocular pressure
Uncommon (0.1% to 1%): Eyelid edema
Nervous systemCommon (1% to 10%): Headache, paresthesia
Postmarketing reports: Dizziness
CardiovascularCommon (1% to 10%): Flushing
Postmarketing reports: Bradycardia, hypotension, orthostatic hypotension
OtherUncommon (0.1% to 1%): Feeling hot, peripheral coldness
GastrointestinalUncommon (0.1% to 1%): Dry mouth
Postmarketing reports: Lip swelling, tongue swelling
HypersensitivityPostmarketing reports: Angioedema, hypersensitivity
LocalPostmarketing reports: Application site pallor, excessive whitening at application site
Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/3/2022.
Source: Drugs.com Mirvaso (www.drugs.com/mirvaso.html).
August 4, 2022
August 4, 2022
August 4, 2022
July 26, 2022
July 26, 2022
July 22, 2022